Skip to main content
Top

Breast Cancer Research and Treatment

Issue 1/2004

Content (9 Articles)

Cytotoxic T Lymphocyte Antigen-4 Gene in Breast Cancer

Abbas Ghaderi, Farshid Yeganeh, Tahereh Kalantari, Abdul Rasoul Talei, Abdul Mohammad Pezeshki, Mehrnoosh Doroudchi, Alamtaj Samsami Dehaghani

Prognostic and Predictive Impact of the HER-2/neu Extracellular Domain (ECD) in the Serum of Patients Treated with Chemotherapy for Metastatic Breast Cancer

Volkmar Müller, Isabell Witzel, Hans Joachim Lück, Günter Köhler, Gunther von Minckwitz, Volker Möbus, Daniel Sattler, Waldemar Wilczak, Thomas Löning, Fritz Jänicke, Klaus Pantel, Christoph Thomssen

Report

Identification of HER2/neu-Derived Peptides Capable of Inducing both Cellular and Humoral Immune Responses in HLA-A24 Positive Breast Cancer Patients

Koichi Azuma, Shigeki Shichijo, Hiroki Shomura, Satoko Matsueda, Teruhiko Fujii, Kyogo Itoh

Report

The Role of MRI in Invasive Lobular Carcinoma

Carla Boetes, Jeroen Veltman, Lya van Die, Peter Bult, Theo Wobbes, Jelle O. Barentsz

Estrogen Responsiveness of IBEP-2, A New Human Cell Line Derived from Breast Carcinoma

Fabrice Journé, Jean-Jacques Body, Guy Leclercq, Denis Nonclercq, Guy Laurent

Growth and EGFR Regulation in Breast Cancer Cells by Vitamin D and Retinoid Compounds

Kenneth R. McGaffin, Lisa E. Acktinson, Susan A. Chrysogelos

Differential Gene Expression of TGFβ Inducible Early Gene (TIEG), Smad7, Smad2 and Bard1 in Normal and Malignant Breast Tissue

Monica M. Reinholz, Ming-Wen An, Steven A. Johnsen, Malayannan Subramaniam, Vera J. Suman, James N. Ingle, Patrick C. Roche, Thomas C. Spelsberg

Erratum

Use of Complementary and Alternative Medicine by Chinese Women with Breast Cancer

Yong Cui, Xiao-Ou Shu, Yutang Gao, Wanqing Wen, Zhi-Xian Ruan, Fan Jin, Wei Zheng

Instructions for Authors

Instructions for Authors

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine